SEC Filing | Abbott Laboratories

View:

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

ALLEN HUBERT L

(Last)

(First)

(Middle)

100 ABBOTT PARK ROAD

(Street)

ABBOTT PARK

60064

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2013

3. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Executive Vice President

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common shares without par value	11,959	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Option (right to buy)⁽¹⁾	06/30/2007	06/29/2016	Common shares	1,134	20.7485	D
Option (right to buy)⁽¹⁾	06/30/2008	06/29/2016	Common shares	1,133	20.7485	D
Option (right to buy)⁽¹⁾	06/30/2009	06/29/2016	Common shares	1,133	20.7485	D
Option (right to buy)⁽¹⁾	02/16/2008	02/15/2017	Common shares	1,134	25.2461	D
Option (right to buy)⁽¹⁾	02/16/2009	02/15/2017	Common shares	1,133	25.2461	D
Option (right to buy)⁽¹⁾	02/16/2010	02/15/2017	Common shares	1,133	25.2461	D
Option (right to buy)⁽¹⁾	02/15/2009	02/14/2018	Common shares	1,534	26.6973	D
Option (right to buy)⁽¹⁾	02/15/2010	02/14/2018	Common shares	1,533	26.6973	D
Option (right to buy)⁽¹⁾	02/15/2011	02/14/2018	Common shares	1,533	26.6973	D

Explanation of Responses:

1. Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

	John A. Berry, by power of attorney for Hubert L. Allen	01/10/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Exhibit 24.1


POWER OF ATTORNEY


The undersigned constitutes and appoints JOHN A. BERRY and JESSICA H.
PAIK, and each of them individually, as the undersigned's true and
lawful attorney-in-fact and agent, with full power of substitution and
re-substitution, for the undersigned and in the undersigned's name,
place and stead, to prepare and sign any and all Securities and
Exchange Commission ("SEC") Notices of Proposed Sales of Securities
pursuant to Rule 144 under the Securities Act of 1933 on Form 144, all
SEC statements on Forms 3, 4 and 5 as required under Section 16(a) of
the Securities Exchange Act of 1934, including a Form ID and any other
documents necessary to obtain codes and passwords necessary to make
electronic filings, and any amendments to such forms, and to file the
same with all exhibits thereto, and other documents in connection
therewith, with the SEC, granting unto said attorney-in-fact and agent
full power and authority to do and perform each act and thing requisite,
necessary or desirable to be done under said Rule 144 and Section 16(a),
as fully for all intents and purposes as the undersigned might or could
do in person, hereby ratifying and confirming all that said attorney-
in-fact and agent may lawfully do or cause to be done by virtue hereof.

A copy of this power of attorney shall be filed with the SEC.  The
authorization set forth above shall continue in full force and effect
until the undersigned is no longer required to file Forms 144, 3, 4, or
5 or if earlier, until the undersigned revokes such authorization by
written instructions to the attorney-in-fact.



Date:  January 2, 2013

/s/ Hubert L. Allen
Signature of Reporting Person

Hubert L. Allen


Abbott Laboratories
100 Abbott Park Road
Abbott Park, IL 60064